Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review
American Journal of Hematology · 2025
DOI: 10.1002/ajh.27506 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Ali Zidan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Kidney Transplantation, Transplantation, Heterologous, Thrombomodulin, Blood Coagulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The recent report of the first pig kidney transplant in a living human brings hope to thousands of people with end‐stage kidney failure. The scientific community views this early success with caution as kidney xenotransplantation exhibits many challenges and barriers. One of these is coagulation dysregulation. This includes (i) pig von Willebrand Factor (vWF) interaction with human platelets, which can induce abnormal clotting responses, heightening the risk of graft failure, (ii) the inefficiency of pig thrombomodulin in activating human protein C, which emphasizes the species‐specific variations that aggravate coagulation challenges, and (iii) the development of thrombotic microangiopathy in the pig grafts and the occurrence of systemic consumptive coagulopathy in the recipients. Indeed, coagulation dysregulation largely results from differences in endothelial cell response and incompatibilities between pig and human coagulation–anticoagulation pathways. These barriers can be resolved by modifications to pig vWF and the expression of human thrombomodulin and endothelial protein C receptors in pig cells, serving as strategic interventions to align the coagulation systems of the two species more closely. These coagulation challenges have clinical implications in how they affect graft survival and patient outcome. Genetic engineering of the organ‐source pig and the administration of various drugs have assisted in correcting this coagulation dysregulation. Hence, comprehending and controlling coagulation dysregulation is crucial for progress in xenotransplantation as a viable option for treating patients with terminal kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Biomedical and Molecular Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada.
- School of Baccalaureate Nursing, St. Lawrence College, Kingston, Ontario, Canada.
- Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
ORCID-Profile: Ali Zidan, Adham H El-Sherbini, Abdelrahman Noureldin, Maha Othman
Förderung
- NIAID NIH HHS
Zitieren
APA
Zidan, A., El-Sherbini, A. H., Noureldin, A., Cooper, D. K. C., & Othman, M. (2025). Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review. American Journal of Hematology. https://doi.org/10.1002/ajh.27506
Vancouver
Zidan A, El-Sherbini AH, Noureldin A, Cooper DKC, Othman M. Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review. American Journal of Hematology. 2025. doi:10.1002/ajh.27506
BibTeX
@article{Zidan2025,
author = {Zidan, Ali and El-Sherbini, Adham H and Noureldin, Abdelrahman and Cooper, David K C and Othman, Maha},
title = {Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.27506}
}
EUVIMED